氟尿苷方案治疗妊娠滋养细胞肿瘤后的生殖结局:中国一家国家级转诊中心的回顾性队列研究
该回顾性队列分析2002年1月至2013年12月在北京协和医院仅接受氟尿苷方案治疗并保留生育功能的464例妊娠滋养细胞肿瘤患者,活产率为72.2%,自然流产率9.2%,人工流产率8.7%,异位妊娠率1.8%,复发率2.1%。 logistic回归显示发病年龄、产次和距化疗间隔是妊娠意愿的独立影响因素;化疗后12个月内36例妊娠中仅1例绒毛膜癌,20例(55.6%)为人工流产。
要点
- 氟尿苷方案治疗后活产率72.2%,复发率2.1%。
- 化疗后1年内妊娠丢失主要原因为人工流产。
- 发病年龄、产次及距化疗间隔影响妊娠意愿。
核心结论
- 氟尿苷方案化疗后,妊娠滋养细胞肿瘤患者保留生育功能治疗后的妊娠率与正常人群相当。
- 化疗结束后一年内的妊娠丢失主要由人工流产导致。
研究设计与样本
- 回顾性分析2002年1月至2013年12月在北京协和医院仅接受氟尿苷方案治疗并保留生育功能的464例妊娠滋养细胞肿瘤患者。
- 采用logistic回归分析影响妊娠意愿的因素。
主要发现
- 464例患者平均年龄28.0±5.7岁,中位随访85个月,活产率72.2%,自然流产率9.2%(n=41),人工流产率8.7%(n=39),异位妊娠率1.8%(n=8),妊娠滋养细胞肿瘤复发率2.1%。
- 人工流产组从化疗结束到首次妊娠的时间显著短于自然流产组、足月/早产组和异位妊娠组(P≤0.001、<0.001、=0.015)。
- logistic分析显示,妊娠滋养细胞肿瘤发病年龄(OR=0.899,95%CI 0.851-0.951,P<0.001)、发病时产次(产次=1,OR=0.123,95%CI 0.068-0.225,P<0.001;产次=2-3,OR=0.058,95%CI 0.014-0.232,P<0.001)和距指数妊娠至化疗的间隔是影响妊娠意愿的独立因素。
- 化疗后12个月内发生的36例妊娠中,仅1例为绒毛膜癌,20例(55.6%)以人工流产告终。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the reproductive outcomes of gestational trophoblastic neoplasia (GTN) patients who were cured only by floxuridine-based regimens. METHODS: This was a retrospective analysis of 464 patients who were treated with only floxuridine-based regimens at Peking Union Medical College Hospital between January 2002 and December 2013 and retained their reproductive ability. Their reproductive outcomes were analyzed. The factors affecting pregnancy intention were identified by logistic regression. RESULTS: Of the 464 patients (average age, 28.0 ± 5.7 years; median follow-up = 85 months), the livebirth rate was 72.2%, while the rates of spontaneous abortion, induced abortion and ectopic pregnancy were 9.2% (n = 41), 8.7% (n = 39) and 1.8% (n = 8), respectively. The GTN recurrence rate was 2.1%. The time from chemotherapy completion to first conception in the induced abortion group was significantly shorter than those in spontaneous abortion, full-term/premature, and ectopic pregnancy groups (P ≤ 0.001, <0.001, =0.015, respectively). The logistic analysis showed that the age at onset of GTN (OR = 0.899, 95% CI 0.851-0.951, P < 0.001), parity at onset of GTN (parity = 1, OR = 0.123, 95% CI 0.068-0.225, P < 0.001; parity = 2-3, OR = 0.058, 95% CI 0.014-0.232, P < 0.001) and interval from the index pregnancy to chemotherapy were independent factors affecting pregnancy intention. Among the 36 pregnancies occurring within 12 months postchemotherapy, only one choriocarcinoma occurred, and 20 culminated in induced abortions (55.6%). CONCLUSIONS: After floxuridine-based chemotherapy, the pregnancy rate of GTN patients after fertility-preserving treatment is comparable to that of the normal population. Pregnancy losses within one year after chemotherapy completion are mainly caused by induced abortion.
引用
- Jiang F, Yang K, Wan XR, et al. Reproductive outcomes after floxuridine-based regimens for gestational trophoblastic neoplasia: A retrospective cohort study in a national referral center in China. Gynecol Oncol. 2020. PMID: 32917411. doi:10.1016/j.ygyno.2020.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。